Athira Pharma logo
Athira Pharma ATHA
$ 0.43 -4.68%

Quarterly report 2024-Q2
added 08-01-2024

report update icon

Athira Pharma Balance Sheet 2011-2024 | ATHA

Annual Balance Sheet Athira Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-89 M -94.1 M -109 M -60.6 M -503 K -2.6 M - - - - - - -

Long Term Debt

1.22 M 1.58 M 1.63 M - 1.55 M 722 K - - - - - - -

Long Term Debt Current

368 K 326 K 288 K 124 K - - - - - - - - -

Total Non Current Liabilities

- - - 876 K 20.6 M 19.2 M - - - - - - -

Total Current Liabilities

28.8 M 21.4 M 9.29 M 4.4 M - - - - - - - - -

Total Liabilities

30.1 M 23 M 10.9 M 5.28 M 21.9 M 19.8 M - - - - - - -

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-309 M -192 M -95.9 M - -21.1 M -15.9 M - - - - - - -

Total Assets

160 M 258 M 332 M 280 M 2.19 M 4.93 M - - - - - - -

Cash and Cash Equivalents

90.6 M 96 M 111 M 60.6 M - - - - - - - - -

Book Value

130 M 235 M 321 M 274 M -19.7 M -14.9 M - - - - - - -

Total Shareholders Equity

130 M 235 M 321 M 274 M -19.7 M - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Athira Pharma

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

1.02 M 1.12 M 1.22 M 1.31 M 1.41 M 1.5 M 1.58 M 1.67 M 1.75 M 1.55 M 1.63 M 1.71 M 1.78 M 1.7 M 876 K 876 K 876 K 876 K 1.55 M 1.55 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

27.9 M 26.7 M 30.1 M 29.9 M 23.1 M 21.6 M 23 M 11.9 M 11.4 M 11 M 10.9 M 11.1 M 9.42 M 6.2 M 5.28 M 5.28 M 5.28 M 5.28 M 4.86 M 4.86 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-362 M -336 M -309 M -282 M -249 M -219 M -192 M -161 M -141 M -117 M -95.9 M -79.6 M -63.9 M -49.9 M -41 M -41 M -41 M -41 M -21.1 M -21.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

111 M 133 M 160 M 185 M 208 M 233 M 258 M 274 M 292 M 313 M 332 M 347 M 360 M 369 M 280 M 280 M 280 M 280 M 2.19 M 2.19 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

73.8 M 77.8 M 90.6 M 110 M 114 M 105 M 96 M 87 M 95.1 M 118 M 111 M 107 M 132 M 128 M 60.6 M 60.6 M 60.6 M 60.6 M 2.06 M 2.06 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

83.3 M 107 M 130 M 155 M 185 M 211 M 235 M 262 M 281 M 302 M 321 M 336 M 351 M 363 M 274 M 274 M 274 M 274 M -2.67 M -2.67 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

83.3 M 107 M 130 M 155 M 185 M 211 M 235 M 262 M 281 M 302 M 321 M 336 M 351 M 363 M 274 M 274 M 274 M 274 M -19.7 M -19.7 M -17.4 M - -14.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency